Bainan Wu

High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.

Bainan Wu, Elisa Barile, Surya K De, 2015, Current topics in medicinal chemistry.

Key Residues Responsible for Acyl Carrier Protein and β-Ketoacyl-Acyl Carrier Protein Reductase (FabG) Interaction*

Bainan Wu, Charles O. Rock, Jie J. Zheng, 2003, Journal of Biological Chemistry.

Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules.

Bainan Wu, Maurizio Pellecchia, Martin G Pomper, 2012, Anti-cancer agents in medicinal chemistry.

Fragment-based design of small molecule X-linked inhibitor of apoptosis protein inhibitors.

Bainan Wu, Maurizio Pellecchia, Kate Welsh, 2008, Journal of medicinal chemistry.

Nuclear magnetic resonance fragment-based identification of novel FKBP12 inhibitors.

Bainan Wu, Maurizio Pellecchia, Ziming Zhang, 2007, Journal of medicinal chemistry.